561 studies found for:    Open Studies | "Infant, Newborn, Diseases"
Show Display Options
Rank Status Study
21 Recruiting Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: QR-010;   Drug: Placebo
22 Recruiting Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
Conditions: Spinal Muscular Atrophy;   Charcot-Marie-Tooth Disease;   Muscular Dystrophy;   Spinal Muscular Atrophy With Respiratory Distress 1;   Amyotrophic Lateral Sclerosis;   Motor Neuron Disease;   Neuromuscular Disease;   Peroneal Muscular Atrophy;   Fragile X Syndrome
Intervention: Other: sample collection
23 Not yet recruiting Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
Condition: Respiratory Distress Syndrome
Interventions: Drug: Lucinactant for inhalation;   Device: nCPAP alone
24 Not yet recruiting Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Furosemide Cohort 1;   Drug: Furosemide Cohort 2;   Drug: Furosemide Cohort 3;   Other: Placebo
25 Recruiting Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
Condition: Cystic Fibrosis
Interventions: Drug: Ceftazidime;   Drug: Tobramycin
26 Not yet recruiting Sirolimus for the Treatment of Hyperinsulinism
Condition: Hyperinsulinism
Intervention: Drug: Sirolimus
27 Not yet recruiting Early Versus Late Caffeine for ELBW Newborns
Conditions: Bronchopulmonary Dysplasia;   Apnea of Prematurity
Interventions: Drug: Caffeine;   Drug: Placebo (dextrose)
28 Recruiting Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia
Conditions: Bronchopulmonary Dysplasia;   Healthy
Intervention: Behavioral: Physical activity program
29 Not yet recruiting Flow-cycled Ventilation in Preterm Infants
Condition: Neonatal Respiratory Distress Syndrome
Interventions: Other: Flow-cycle ventilation;   Other: Time-cycle ventilation mode
30 Not yet recruiting Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)
Condition: Cystic Fibrosis
Interventions: Dietary Supplement: MAG-DHA;   Dietary Supplement: Placebo
31 Recruiting A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: VX-661;   Drug: ivacaftor;   Drug: placebo
32 Recruiting A Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects With CF, Homozygous for the F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: VX-809;   Drug: Placebo;   Drug: VX-770
33 Not yet recruiting Reevaluation Of Systemic Early Neuromuscular Blockade
Condition: Acute Respiratory Distress Syndrome
Intervention: Drug: cisastracurium besylate
34 Not yet recruiting A Phase 2 Study to Evaluate Effects of VX-661/Ivacaftor on Lung and Extrapulmonary Systems in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Condition: Cystic Fibrosis
Interventions: Drug: VX-661/ivacactor;   Drug: ivacaftor;   Drug: VX-661/ ivacaftor matching placebo;   Drug: ivacaftor matching placebo
35 Recruiting Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol 0.2% eye drops
36 Not yet recruiting Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Ceftazidime/avibactam
37 Not yet recruiting Investigating the Use of a Positive Parenting Programme to Improve Treatment Adherence in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Behavioral: Self-directed Teen Triple P
38 Not yet recruiting Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Condition: Cystic Fibrosis
Intervention: Drug: Nitric Oxide 160 ppm
39 Not yet recruiting The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: novolog insulin;   Drug: levemir insulin;   Drug: placebo
40 Not yet recruiting Sustained Lung Inflation and Pulmonary Mechanics in Preterm Infant
Conditions: Preterm Birth;   Respiratory Distress Syndrome;   Lung Diseases
Interventions: Other: Sustained lung inflation;   Device: mask using a T-piece system (Fabian,Acutronic Medical Systems AG, Switzerland).

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years